About a week after the FDA convened its latest meeting to discuss strategies for reducing racial biases in widely available pulse oximetry technology, Masimo has released new study data suggesting ...

Wearable devices have become essential to clinical research, as they enable research studies to collect health-related data on patients around the clock. These devices, which includes commercial ...

Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...

This morning medical device company Masimo announced FDA clearance for the measurement of respiration rate from a photoplethysmogram (RRp), so that it may now be used on the MightSat Rx finger pulse ...

Masimo, a medical device company best known for its pulse oximeter technology, is going up against Apple. Its CEO, Joe Kiani, is leading an audacious lawsuit, investing a whopping $100 million - a ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.

Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...